Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess

References

• Scippo ML, Frankenne F, Hooghe-Peters EL, Igout A, Velkeniers B, Hennen G. Syncytiotrophoblastic localization of the human growth hormone variant mRNA in the placenta. Mol Cell Endocrinol 1993; 92: R7–13
   PubMed Web of Science ®Google Scholar
• Caufriez A, Frankenne F, Hennen G, Copinschi G. Regulation of maternal insulin-like growth factor I by placental growth hormone in pregnancy. Possible action of maternal IGF-I on fetal growth. Horm Res 1994; 42: 62–5
   PubMedGoogle Scholar
• Frankenne F, Closset J, Gomez F, Scippo ML, Smal J, Hennen G. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 1988; 66: 1171–80
   PubMed Web of Science ®Google Scholar
• Eriksson L, Frankenne F, Eden S, Hennen G, Von Schoultz B. Growth hormone 24-h serum profiles during pregnancy – lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 1989; 96: 949–53
   PubMedGoogle Scholar
• Chellakooty M, Skibsted L, Skouby SO, Andersson AM, Petersen JH, Main KM, et al. Longitudinal study of serum placental GH in 455 normal pregnancies: correlation to gestational age, fetal gender, and weight. J Clin Endocrinol Metab 2002; 87: 2734–9
   PubMed Web of Science ®Google Scholar
• Boguszewski CL, Boguszewski MC, de Zegher F, Carlsson B, Carlsson LM. Growth hormone isoforms in newborns and postpartum women. Eur J Endocrinol 2000; 142: 353–8
   PubMed Web of Science ®Google Scholar
• Caufriez A, Frankenne F, Englert Y, Golstein J, Cantraine F, Hennen G, et al. Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol 1990; 258: E1014–9
   PubMed Web of Science ®Google Scholar
• Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab 1990; 71: 797–805
   PubMed Web of Science ®Google Scholar
• Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab 1990; 71: 806–16
   PubMed Web of Science ®Google Scholar
• Chellakooty M, Vangsgaard K, Larsen T, Scheike T, Falck-Larsen J, Legarth J, et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab 2004; 89: 384–91
   PubMed Web of Science ®Google Scholar
• Dai J, Scott CD, Baxter RC. Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes. Endocrinology 1994; 135: 1066–72
   PubMed Web of Science ®Google Scholar
• Schmid C, Brandle M, Zwimpfer C, Zapf J, Wiesli P. Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor. Clin Chem 2004; 50: 228–31
   PubMed Web of Science ®Google Scholar
• Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986; 154: 138–43
   PubMed Web of Science ®Google Scholar
• Zapf J, Schmid C, Guler HP, Waldvogel M, Hauri C, Futo E, et al. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest 1990; 86: 952–61
   PubMed Web of Science ®Google Scholar
• Schmid C, Ghirlanda-Keller C, Zapf J. Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects. Eur J Endocrinol 2001; 145: 213–21
   PubMed Web of Science ®Google Scholar
• Schmid C, Schlapfer I, Keller A, Waldvogel M, Froesch ER, Zapf J. Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth. Biochem Biophys Res Commun 1995; 212: 242–8
   PubMed Web of Science ®Google Scholar
• Schmid C, Keller C, Gosteli-Peter M, Zapf J. Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10. Biochem Biophys Res Commun 1999; 263: 786–9
   PubMed Web of Science ®Google Scholar
• Curran AJ, Peacey SR, Shalet SM. Is maternal growth hormone essential for a normal pregnancy?. Eur J Endocrinol 1998; 139: 54–8
   PubMed Web of Science ®Google Scholar
• Hall K, Enberg G, Hellem E, Lundin G, Ottosson-Seeberger A, Sara V, et al. Somatomedin levels in pregnancy: longitudinal study in healthy subjects and patients with growth hormone deficiency. J Clin Endocrinol Metab 1984; 59: 587–94
   PubMed Web of Science ®Google Scholar
• Verhaeghe J, Bougoussa M, Van Herck E, de Zegher F, Hennen G, Igout A. Placental growth hormone and IGF-I in a pregnant woman with Pit-1 deficiency. Clin Endocrinol (Oxf) 2000; 53: 645–7
   PubMed Web of Science ®Google Scholar
• Menashe Y, Sack J, Mashiach S. Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation?. Hum Reprod 1991; 6: 670–1
   PubMed Web of Science ®Google Scholar
• Wiren L, Boguszewski CL, Johannsson G. Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy. Clin Endocrinol (Oxf) 2002; 57: 235–9
   PubMed Web of Science ®Google Scholar
• Herman-Bonert V, Seliverstov M, Melmed S. Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 1998; 83: 727–31
   PubMed Web of Science ®Google Scholar
• Wilson DM, Bennett A, Adamson GD, Nagashima RJ, Liu F, DeNatale ML, et al. Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies. J Clin Endocrinol Metab 1982; 55: 858–61
   PubMed Web of Science ®Google Scholar
• Fuglsang J, Lauszus F, Orskov H, Ovesen P. Placental growth hormone during pregnancy in a growth hormone deficient woman with type 1 diabetes compared to a matching diabetic control group. Growth Horm IGF Res 2004; 14: 66–70
   PubMed Web of Science ®Google Scholar
• Whittaker PG, Stewart MO, Taylor A, Howell RJ, Lind T. Insulin-like growth factor 1 and its binding protein 1 during normal and diabetic pregnancies. Obstet Gynecol 1990; 76: 223–9
   PubMed Web of Science ®Google Scholar